http://www.psychiatrist.com/JCP/article/Pages/2018/v79n03/17m11753.aspx
4 Likes
“The BACS token motor (P = .04), verbal fluency (P = .01), and composite z scores (P = .05) showed significant improvements in the MIN-101 32 mg group compared to the placebo group. At week 4, the clinical improvements from baseline in the Positive and Negative Syndrome Scale (PANSS) negative factor showed a significant correlation with improvements from baseline on the BACS composite in the 64 mg group (r = −0.292, P = .020). At week 12, improvement in the PANSS negative factor showed significant correlations with improvements in the BACS composite (r = −0.408, P = .002), Trail Making Test (r = −0.394, P = .003), and verbal memory (r = −0.322, P = .017) for the 64 mg group.”
“Conclusions: Results suggest a possible benefit of MIN-101 on cognitive performance in individuals with schizophrenia with stable positive symptoms and concurrent clinically significant negative symptoms.”
3 Likes
It says it is good for cognitive symptoms too… is it guys…???
Yes, for some aspects of cognition; visual attention, task switching, and verbal memory.
1 Like